Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme

Fig. 1

Australian Scleroderma Cohort Study algorithm for screening for pulmonary hypertension. ANA antinuclear antibody, ENA extractable nuclear antibody, CXR chest radiograph, ECG electrocardiogram, TTE transthoracic echocardiogram, PFT pulmonary function test, 6MWT six-minute walk test, PAH pulmonary arterial hypertension, sPAP systolic pulmonary arterial pressure, DLCO diffusing capacity of the lung for carbon monoxide corrected for haemoglobin, RHC right-heart catheterization, HRCT high-resolution chest computed tomography, V/Q ventilation perfusion, CTPA computed tomography pulmonary angiography

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us